The Global Crypto Exchange, OKEx Aims to Enter the Indian Market
Announces free USDT being distributed to allure Indian crypto traders
Disclaimer: Trading digital assets involves significant risk and can result in the loss of your invested capital. You should ensure that you fully understand the risk involved and take into consideration your level of experience, investment objectives and seek independent financial advice if necessary.
While the existing Indian crypto exchanges are struggling to survive the regulatory storm in India, OKEx, the Hong Kong-based crypto exchange plans to establish the stronghold in the Indian crypto landscape. Realizing the potential in India, OKEx announced their second token sale on their launchpad — OK Jumpstart on May 16, 2019.
Swiss based ETP enters the Crypto trading market – Data Driven Investor
OKEx to captivate from Bitcoin’s price surge
Bitcoin, the world’s largest cryptocurrency has garnered everyone’s attention by surging nearly by 50% just during the last month. Bitcoin has not seen this kind of price action in over a year now and for the Bitcoin to break the long-lasting resistance of $4,200 triggered the bullish momentum for Bitcoin’s crypto cousins.
The timing could not have been better for OKEx to enter the Indian market as the search trend for Bitcoin trading has been on the spurt.
The previous token sale was for the Blockcloud project and its native BLOC token and this was sold out in a single second, beating even competing for exchange Binance’s speed of 22 seconds for the Fetch.AI token.
The second token sale is for ALLIVE token, the first subscription session will open at 05:00 (CET, UTC+1), and the second session will open at 06:00 (CET, UTC+1) on the mentioned date.
Deep-dive into the Allive token
ALLIVE is an intelligent healthcare ecosystem based on blockchain technology. This project aims to provide standardized formats for health data integration, protect data privacy and support extension compatibility. ALLIVE has partnered with Ontology, a public blockchain and distributed trust collaboration platform for data sharing.
ALLIVE has over a million existing users from the traditional healthcare space. In the last 3 years, the team has been building a general AI doctor and a comprehensive healthcare system based on three modules: Olive, Olivia, and Oleaf. The team has more than 15 years of experience in the healthcare industry. ALLIVE network has DAPP integration in the roadmap and this would bring 20 healthcare applications in their network once complete. Their strategic partners include blockchain tech moguls such as WanXiang Blockchain Labs and Ontology.
Why enter the Indian crypto market with Allive token?
OK Jumpstart is keen on blockchain projects that have tremendous potential in the space and ALLIVE is a project that is building a sustainable smart health community to enhance the existing healthcare ecosystem, making it more accessible and affordable for everyone.
The price for this sale was announced to be 1 ALV = $0.006, with the price of OKB being around USD 2.
The exchange price will be confirmed by the OKB price on the launch date. Users could subscribe for a minimum of 100,000 ALV or as high as 666,666 ALV. The supply for the first and second session is 150,000,000 ALV. The over-subscription limit is 300,000,000 ALV for the first session. The subscription is available on both OKEx.com and OKEx Mobile App.
Holders will be able to trade their ALV against the exchange’s native OKB token starting 08:00 May 16, 2019 (CET, UTC+1) and Tether (USDT) starting 08:00 May 17, 2019 (CET, UTC+1). To ensure the subscription process is fair and secure, verification code is not required for subscription.
For more information, please refer to “OK Jumpstart Project Introduction — ALLIVE”. Join their Indian Telegram Community for more information and rules on entering the tokensale.
Global crypto exchange, OKEx aims to enter Indian market was originally published in Data Driven Investor on Medium, where people are continuing the conversation by highlighting and responding to this story.